Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Gut-associated IgA+ immune cells regulate obesity-related insulin resistance.

Luck H, Khan S, Kim JH, Copeland JK, Revelo XS, Tsai S, Chakraborty M, Cheng K, Tao Chan Y, Nøhr MK, Clemente-Casares X, Perry MC, Ghazarian M, Lei H, Lin YH, Coburn B, Okrainec A, Jackson T, Poutanen S, Gaisano H, Allard JP, Guttman DS, Conner ME, Winer S, Winer DA.

Nat Commun. 2019 Aug 13;10(1):3650. doi: 10.1038/s41467-019-11370-y.

2.

Macrophage JAK2 deficiency protects against high-fat diet-induced inflammation.

Desai HR, Sivasubramaniyam T, Revelo XS, Schroer SA, Luk CT, Rikkala PR, Metherel AH, Dodington DW, Park YJ, Kim MJ, Rapps JA, Besla R, Robbins CS, Wagner KU, Bazinet RP, Winer DA, Woo M.

Sci Rep. 2017 Aug 9;7(1):7653. doi: 10.1038/s41598-017-07923-0.

3.

Type I Interferon Responses Drive Intrahepatic T cells to Promote Metabolic Syndrome.

Ghazarian M, Revelo XS, Nøhr MK, Luck H, Zeng K, Lei H, Tsai S, Schroer SA, Park YJ, Chng MHY, Shen L, D'Angelo JA, Horton P, Chapman WC, Brockmeier D, Woo M, Engleman EG, Adeyi O, Hirano N, Jin T, Gehring AJ, Winer S, Winer DA.

Sci Immunol. 2017 Apr 21;2(10). pii: eaai7616. doi: 10.1126/sciimmunol.aai7616.

4.

Nucleic Acid-Targeting Pathways Promote Inflammation in Obesity-Related Insulin Resistance.

Revelo XS, Ghazarian M, Chng MH, Luck H, Kim JH, Zeng K, Shi SY, Tsai S, Lei H, Kenkel J, Liu CL, Tangsombatvisit S, Tsui H, Sima C, Xiao C, Shen L, Li X, Jin T, Lewis GF, Woo M, Utz PJ, Glogauer M, Engleman E, Winer S, Winer DA.

Cell Rep. 2016 Jul 19;16(3):717-30. doi: 10.1016/j.celrep.2016.06.024. Epub 2016 Jun 30.

5.

Starving Intestinal Inflammation with the Amino Acid Sensor GCN2.

Revelo XS, Winer S, Winer DA.

Cell Metab. 2016 May 10;23(5):763-5. doi: 10.1016/j.cmet.2016.04.020.

6.

Immunopathology of Adipose Tissue during Metabolic Syndrome.

Ghazarian M, Luck H, Revelo XS, Winer S, Winer DA.

Turk Patoloji Derg. 2015;31 Suppl 1:172-80. doi: 10.5146/tjpath.2015.01323. Review.

7.

DJ-1 links muscle ROS production with metabolic reprogramming and systemic energy homeostasis in mice.

Shi SY, Lu SY, Sivasubramaniyam T, Revelo XS, Cai EP, Luk CT, Schroer SA, Patel P, Kim RH, Bombardier E, Quadrilatero J, Tupling AR, Mak TW, Winer DA, Woo M.

Nat Commun. 2015 Jun 16;6:7415. doi: 10.1038/ncomms8415.

8.

Are obesity-related insulin resistance and type 2 diabetes autoimmune diseases?

Tsai S, Clemente-Casares X, Revelo XS, Winer S, Winer DA.

Diabetes. 2015 Jun;64(6):1886-97. doi: 10.2337/db14-1488. Review.

9.

Regulation of obesity-related insulin resistance with gut anti-inflammatory agents.

Luck H, Tsai S, Chung J, Clemente-Casares X, Ghazarian M, Revelo XS, Lei H, Luk CT, Shi SY, Surendra A, Copeland JK, Ahn J, Prescott D, Rasmussen BA, Chng MH, Engleman EG, Girardin SE, Lam TK, Croitoru K, Dunn S, Philpott DJ, Guttman DS, Woo M, Winer S, Winer DA.

Cell Metab. 2015 Apr 7;21(4):527-42. doi: 10.1016/j.cmet.2015.03.001.

10.

Perforin is a novel immune regulator of obesity-related insulin resistance.

Revelo XS, Tsai S, Lei H, Luck H, Ghazarian M, Tsui H, Shi SY, Schroer S, Luk CT, Lin GH, Mak TW, Woo M, Winer S, Winer DA.

Diabetes. 2015 Jan;64(1):90-103. doi: 10.2337/db13-1524. Epub 2014 Jul 21.

11.

Morphological and inflammatory changes in visceral adipose tissue during obesity.

Revelo XS, Luck H, Winer S, Winer DA.

Endocr Pathol. 2014 Mar;25(1):93-101. doi: 10.1007/s12022-013-9288-1. Review.

PMID:
24356782
12.
13.

Supplemental Content

Loading ...
Support Center